← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
SV Life Sciences Fund VI (GP), L.P.
10% Owner
Identity: Name is scoped to this issuer; it is not merged with equal names at other companies · Reporting-owner CIK: Unavailable
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 1
- Purchases · 24M
- 1
- Average purchase
- $1.3M
- Median purchase
- $1.3M
- Gross purchase value
- $1.3M
Companies: TRex Bio, Inc.
1 SEC accession(s) · 1 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-10-13 | TRex Bio, Inc. | TRXB | 10% Owner | $1.3M | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
No completed point-in-time price outcome is available yet.
Research patterns
- First purchase in 12M
- 1/1
- Large purchase ≥ $100k
- 1/1
- Cluster buying · 15D
- 1/1
- Buying the dip
- 0/—
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.